Otherside Farms

MAY 6, 2019

ASD usually develops during childhood and is a neurodevelopmental condition which often involves compulsive and repetitive behavior. We still don’t know what causes the development of ASD, with scientists believing that it is probably a mixture of genetic and environmental factors. ASD and Epilepsy. CBD and Epilepsy.

Epilepsy 77

Epilepsy CBD Research and Development Therapy 77

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. –(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., as its Research Director, a new role in the organization’s leadership.

Data 81

Data Epilepsy Research and Development Clinical Trials 81

Cannabis Law Report

JULY 13, 2021

Australia’s Victorian government says Agriculture Victoria Research scientists have developed the world’s most complete medicinal cannabis genomic reference. The organisation has been licensed by the Australian Government to undertake medicinal cannabis research. Hemp Gazette reports. Source: [link].

Medicine 81

Medicine Research and Development Agriculture Compliance 81

The Cannigma

JUNE 29, 2021

Though the distinction between these terms may seem trivial at first glance, it is in fact crucial for cannabis research, and therefore also for consumers and regulators as well. Researchers conducting survey based studies today often only have access to the THC concentration of the cannabis that their participants are using.

Terpenes 138

Terpenes Research and Development Cannabinoids Concentrates 138

Sensi Seeds

DECEMBER 10, 2018

At the same time, research on medical cannabis over the past two decades has not ceased to increase and provide evidence of the plant’s medical value. As a result, medical and scientific research has been highly constrained for many decades. Exponential Increase in Cannabis Research: Trends.

Medicine 81

Medicine Research and Development Data Policy 81

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. The two cannabinoids can also cause very different effects in other ways.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Medicinal Marijuana Association

AUGUST 27, 2019

Extensive research in the United States and England on cannabis in the 1930s came to a halt with the beginning of World War II and did not pick up again afterwards due to the various laws and regulations that classified the plant as a drug.Legal issuescontinued to inhibit serious study until half a century ago, when Prof.

Research and Development 66

Research and Development Clinical Trials Patients Epilepsy 66

Puff Puff Post

OCTOBER 3, 2019

Previous success from treating epilepsy with Cannabinoids now motivates doctors to investigate the plant’s effectiveness in treating symptoms of autism. In a 47 acre greenhouse – close to the size of 42 football fields – GW is developing and delivering strains of medicinal cannabis.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

MMJ Recs

DECEMBER 28, 2023

In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option. CBD, a non-psychoactive cannabinoid, has gained attention for its anti-anxiety effects.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Cannabis Law Report

AUGUST 10, 2021

The UK is a significant country for us for many reasons, and we are proud to be able to offer a medicine, that has been developed and is manufactured here, to even more patients across the UK. GW’s development programme represents the only well-controlled clinical evaluation of a cannabinoid medication for patients with refractory epilepsy.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. The company has begun preparation that will facilitate the commencement of the clinical study and engaged with a contract research organization (CRO) to provide support for the trial.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

PrestoDoctor

SEPTEMBER 26, 2023

Research suggests that cannabis can affect various aspects of mental health , including mood, cognition, and behavior. It’s important to note that not everyone who uses cannabis will develop mental health issues. Research suggests that there is indeed a link between cannabis use and mental health issues.

Research and Development 105

Research and Development Chronic Pain Sleep Conditions 105

MMJ Recs

FEBRUARY 3, 2021

Cannabinoids are a group of chemical substances that exist both within the human body and in nature. Cannabinoids make up the endocannabinoid system in the body, a system that plays a role in communication between the brain and the body. In medical marijuana, cannabinoids are found in the cannabis sativa plant.

Cannabinoids 52

Cannabinoids Patients Blood Pressure Chronic Pain 52

Leaf Science

FEBRUARY 19, 2019

When using mice who had been selectively bred to develop symptoms associated with depression (such as lethargy and immobility), researchers found that CBD treatment was linked to a reduction in immobility during a forced swim test, a commonly used test used to study depressive symptoms. CBD and Traditional Antidepressants.

CBD 101

CBD Research and Development Treatment Epilepsy 101

CannaMD

AUGUST 8, 2020

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. However, many of these products contain a number of other cannabinoids as well. To understand cannabinoids, we need to take a closer look at the endocannabinoid system. In 1970, the U.S.

CBD 105

CBD DEA Research and Development Hemp 105

MMJ Recs

MAY 25, 2024

Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. Let’s go over the three main components of ECS to better understand, they are: endocannabinoids, cannabinoid receptors, and enzymes.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Cannabinoids even alleviate certain types of pain that opiates don’t always treat well. Approved Cannabinoid-Based Medications.

Treatment 49

Treatment Clinical Trials Research and Development Cannabinoids 49

Cannabis Law Report

AUGUST 2, 2021

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug. after injection.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

United Patients Group

JULY 7, 2023

While there is still much research to be done on the potential benefits and risks of medical cannabis, there is a growing body of evidence that suggests it can be a valuable tool for managing chronic pain, anxiety and depression, nausea and vomiting, seizures, inflammation, sleep, and other health conditions.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

Medicinal Marijuana Association

FEBRUARY 10, 2024

With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. Understanding how to discern reliable sources, interpret research methodologies, and apply key findings to real-world scenarios can be daunting.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

United Patients Group

OCTOBER 25, 2023

Medical marijuana’s therapeutic effects are primarily due to its active compounds, known as cannabinoids. The two primary cannabinoids are delta-9-tetrahydrocannabinol ( THC ) and cannabidiol ( CBD ). Can You Become Addicted to Medical Marijuana?

Marijuana 105

Marijuana Patients Research and Development Edibles 105

Alchimia

JUNE 20, 2016

CBD is a cannabinoid present in cannabis plants with a very similar molecular structure to THC but without any kind of psychoactive effect. It has been demonstrated that CBD has low affinity with the CB1 and CB2 cannabinoid receptors , but it does act on other receptors of the human body like GPR55 or 5-HT1A. What is CBD?

Medicine 76

Medicine CBD Research and Development Epilepsy 76

Medicinal Marijuana Association

FEBRUARY 11, 2024

Have you ever wondered how cannabinoids interact with your body’s systems? From influencing mood and memory to regulating pain and appetite, cannabinoids play a crucial role in maintaining balance within the body. Key Takeaways Cannabinoids like THC and CBD impact the body through various receptors and maintain balance.

Cannabinoids 52

Cannabinoids Chronic Pain Blood Pressure Research and Development 52

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Veriheal

JANUARY 18, 2023

In 2018, legislation was passed by the British Parliament that effectively legalized cannabinoids like CBD and CBDA. Research commissioned by the Centre for Medicinal Cannabis pinned a £1 billion valuation on the CBD market by the year 2025. Confusion surrounding British CBD laws has thrust the cannabinoid into a legal gray area.

CBD 97

CBD Strains Research and Development Oil 97

United Patients Group

FEBRUARY 2, 2023

It’s made up of endocannabinoids and cannabinoid receptors, which work together to maintain homeostasis in the body by regulating things like mood, energy, appetite and sleep cycles. The ECS has been studied for its role in many diseases including cancer , epilepsy, chronic pain and multiple sclerosis (MS). antibiotics).

Blood Pressure 105

Blood Pressure Sleep Chronic Pain Digestion 105

The Herb Collective

AUGUST 1, 2023

The cannabinoids found in Cannabis Indica have been shown to have a relaxing effect on the body, which causes a decrease in blood pressure. While the exact mechanisms behind this phenomenon are still being researched, the results are promising.

Indica 87

Indica Blood Pressure Epilepsy Sleep 87

Canna Law Blog

OCTOBER 31, 2019

Epidiolex is a drug that was created by Cambridge, UK-based GW Pharmaceuticals and was approved by the FDA as a drug in 2018 to help relieve epilepsy-induced seizures. GW Pharmaceuticals has now done two decades’ worth of research on CBD and other cannabinoids and is responsible for putting CBD on the FDA’s radar many years ago.

Pharmaceutical 72

Pharmaceutical Research and Development Cannabinoids Food 72

Cannabis Law Report

DECEMBER 23, 2021

Research on the endocannabinoid system is one of the most promising avenues for new therapeutics in medicine at the moment. This report has been compiled to assist interested parties in understanding the market for the medical use of cannabinoids and where it may be heading. C3 Cannabinoid Compound Company. Companies Mentioned.

Pharmaceutical 74

Pharmaceutical Clinical Trials Research and Development Cannabinoids 74

Veriheal

DECEMBER 8, 2023

The report is expected to touch on the following: The medical potential of cannabis and CBD for serious conditions like epilepsy The effects of delta-9 THC on brain development, and driving abilities Barriers to cannabis research in states where cannabis is illegal Recommendations on regulations and testing needed for more accurate cannabinoid level (..)

Recreational 105

Recreational Research and Development Epilepsy THC 105

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Cannabinoids even alleviate certain types of pain that opiates don’t always treat well. Approved Cannabinoid-Based Medications.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Cannabis Law Report

JANUARY 10, 2022

Minor Cannabinoids Market Size, Share & Trends Analysis Report by Product (CBG, CBC, CBN, THCV, CBGA), by Application (Pain Management, Neurological Disorders), and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering. minor cannabinoids market size is expected to reach USD 26.2

Cannabinoids 40

Cannabinoids Clinical Trials Research and Development Supply Chain 40

Veriheal

SEPTEMBER 27, 2021

Individuals with this condition have to find ways to deal with the fact that their immune system is attacking the protective sheath of nerve fiber surrounding the nerve cells, putting the body in a state of imbalance that results in muscle spasms, paralysis, disrupted bladder function, mental changes, depression, and even epilepsy.

Treatment 98

Treatment Patients Access Research and Development 98

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

NOVEMBER 29, 2019

For instance, THC has shown the potential to help in the treatment of conditions like PTSD, depression, eating disorders, and epilepsy. When a person uses a THC oil pen ( vapingdaily gives more details) to ingest this cannabinoid, it can benefit them in different ways. However, cannabinoids use modulation. THC Oil Benefits.

Oil 80

Oil THC Cannabinoids Research and Development 80